Human Vaccines & Immunotherapeutics

Article	Citations
Human vaccines & immunotherapeutics: News October 2022	165
Willingness of college students to receive COVID-19 heterologous vaccination in Taizhou, China	109
Vaccine manufacturing is essential to ensure access	104
Human vaccines and immunotherapeutics: News December 2023	104
Comment on the “Analysis of the implementation effect and evaluation of the vaccine protection effect of the live attenuated varicella vaccine program for school-age children in Bao’an district of She	98
Do Pentavalent (DTwP-Hib-HBV) vaccines have sex-differential nonspecific effects? An observational study	85
Estimation of single-dose varicella vaccine effectiveness in South Korea using mathematical modeling	79
Healthcare workers’ and caregivers’ knowledge, perceptions and experiences of the school-based human papillomavirus (HPV) immunization program: A qualitative study in eThekwini District of the KwaZulu	75
Global research trends in CAR-T cell therapy for solid tumors: A comprehensive visualization and bibliometric study (2012–2023)	74
Determinants of basic childhood vaccination coverage in European and OECD countries	66
Challenges to COVID-19 vaccine introduction in the Democratic Republic of the Congo – a commentary	64
Enhancing COVID-19 booster vaccination among the elderly through text message reminders	64
Review of the epidemiology, diagnosis and management of invasive meningococcal disease in Vietnam	63
Impaired long-term anti-HBs responses in choronic hepatitis C patients: Results from a five-year follow-up study with healthy control	63
Factors influencing COVID-19 vaccine acceptance and hesitancy: Correspondence	62
Correction	60
Acute encephalitis after COVID-19 vaccination: A case report and literature review	60
Drivers and barriers to influenza vaccination in the post–COVID-19 era in the Federation of Bosnia and Herzegovina: A qualitative study using focus groups with risk groups and in-depth interviews with	58
A One Health approach to bovine coronavirus vaccine development, using LSDV as a live virus vector	57
Systematic literature review and meta-analysis on the prevalence of rotavirus genotypes in Asia from 2015 to 2021	56
Bacteriophages as vaccine platforms: Opportunities and challenges in translation	55
PV-10 enhances immune responses in hepatitis B vaccination through STING pathway	52
Understanding barriers to influenza vaccination among parents is important to improve vaccine uptake among children	51
HV&I Reviewer Highlight	51
Beliefs and barriers of COVID-19 vaccination hesitancy among Sudanese healthcare workers in Sudan: A cross sectional study	48

Long-term follow up of patients treated with a DNA vaccine (pTVG-hp) for PSA-recurrent prostate cancer	48
The potential effect of HBV vaccination on off-treatment HBsAg reversion after interferon-induced HBsAg clearance	46
Coadministration of seasonal influenza and COVID-19 vaccines: A systematic review of clinical studies	45
Improving Tdap maternal immunization rate in Saudi Arabia	43
Factors associated with willingness to accept pneumococcal vaccine based on the Health Belief Model among the elderly (≥60 years) living in Klang Valley, Malaysia	41
Medical students’ knowledge about human papillomavirus (HPV), HPV vaccine and head and neck cancer	41
Safety and immunogenicity of quadrivalent meningococcal polysaccharide vaccine (MPV ACYW135) compared with quadrivalent meningococcal conjugate vaccine (Menactra®) in Malian children	39
Booster vaccines dose reduced mortality in hospitalized COVID-19 patients requiring oxygen supplementation: Evidence from the Beijing Omicron outbreak	39
Characterizing adolescent vaccination in publicly funded national immunization programs in Latin America and the Caribbean: A review of the literature	39
Individual and neighborhood factors associated with being unvaccinated against COVID-19 among pregnant persons	38
Childhood vaccination uptake among children born in Aotearoa New Zealand based on parental nationality	38
Impact of propensity to COVID-19 vaccination/vaccine on influenza vaccination from willingness to behavior among older adults in rural China	38
The public health impact of recombinant herpes zoster vaccination in adults over 50 years in Spain	38
Associations between vaccination clinic factors and DTaP dropout in China: A cross-sectional study	36
The effect of preexisting antibodies from Tdap vaccination during pregnancy on infant antibody responses to the pertussis-containing vaccines	36
Harnessing live vectors for cancer vaccines: Advancing therapeutic immunotherapy	36
Age- and time-dependent waning vaccine effectiveness of PPV23 against community-acquired pneumonia among adults aged 60 and older: A cohort study	35
A Bayesian re-analysis of the DANFLU-1 trial	35
Acceptability of patient-centered digital vaccine safety monitoring: A Canadian Immunization Research Network study	35
Efficiency enhancement in main path extraction in mRNA vaccine field: A novel approach leveraging intermediate patents, with shielding origin and terminus patent edges	35
A cross-sectional study assessing Pro-VC-Be short-form questionnaire in Canada; measuring psychosocial determinants of vaccination behavior in Canadian healthcare professionals	34
Pharmacovigilance assessment of adverse events following yellow fever vaccination: Disproportionality analysis of VAERS reports, 2015–2025	34
A novel anti-PcrV monoclonal antibody inhibits toxin-mediated cytotoxicity and enhances survival in mouse models of Pseudomonas aeruginosa infection	33
Recent advances in immunotherapy targeting CETP proteins for atherosclerosis prevention	33
Single-cell analysis unravels the role of NK cells and monocytes in the control of SARS-CoV-2 breakthrough infections in vaccinated individuals	33
Geographical and time trends of measles incidence and measles vaccination coverage and their correlation in Nigeria	33
Visual analysis of the research frontiers, hotspots and development trends of immunization programs for women and children	33
Health, beliefs, and faith: HPV vaccine uptake intent among Catholic, Evangelical, and mainline protestant parents	32
Immune response to and virological profile of SARS-CoV-2 before and after symptom onset in individuals vaccinated with inactivated COVID-19 vaccines	32
Immunological non-inferiority and safety of a quadrivalent inactivated influenza vaccine versus two trivalent inactivated influenza vaccines in China: Results from two studies	32
How to make effective HPV vaccine recommendations starting at age 9	32
Uptake, adverse effect, and associated factors of COVID-19 vaccine among those living with human immunodeficiency virus, at Bole sub-city health facility Addis Ababa, Ethiopia	32
Assessment of COVID-19 vaccine take-up and its predictors among healthcare professionals in public hospitals, Addis Ababa, Ethiopia: Facility-based cross-sectional study	32
Community based participatory research as a promising practice for addressing vaccine hesitancy, rebuilding trust and addressing health disparities among racial and ethnic minority communities	32
Implementing interventions to start HPV vaccination at age 9: Using the evidence we have	32
HV&I Reviewer Highlight	31
Revamping the BCG revaccination strategy: Records to recall, or just call it phoenix?	31
Adverse events after COVID-19 vaccination self-reported by healthcare workers are reliable	31
Determinants of immunization defaulters among children aged 12–23 months in Ambo town, Oromia, Ethiopia: A case–control study	31
“Direct and indirect impacts of the COVID-19 pandemic on operational conduct of pediatric vaccine clinical trials”	31
Pertactin deficiency of Bordetella pertussis : Insights into epidemiology, and perspectives on surveillance and public health impact	31
Mumps serological surveillance following 10 years of a one-dose mumps-containing-vaccine policy in Fujian Province, China	31
Attitudes and behavior of medical students toward receiving the COVID-19 vaccine	31
CEA vaccines	30
Intention to receive a COVID-19 vaccine booster dose and associated factors in Malaysia	30
Development of a herpes zoster vaccination intention scale and identification of factors associated with vaccine hesitancy among middle-aged and older attendees in community health centers: A Protecti	29
Hospitalization burden associated with anus and penis neoplasm in Spain (2016-2020)	29
Statistical and machine learning methods for immunoprofiling based on single-cell data	29
Vaccine hesitancy in the refugee, immigrant, and migrant population in the United States: A systematic review and meta-analysis	29
Reply letter to “Immunogenicity and safety of a quadrivalent high-dose inactivated influenza vaccine compared with a standard-dose quadrivalent influenza vaccine in healthy people aged 60 years or old	29

Integrating the CARD (Comfort Ask Relax Distract) system in a mass vaccination clinic to improve the experience of individuals during COVID-19 vaccination: a pre-post implementation study	28
Human Papillomavirus vaccine knowledge and recommendation practice among primary care providers, Almaty, Kazakhstan – 2023	28
BC02-adjuvanted varicella-zoster virus glycoprotein E subunit vaccine overcomes immunosenescence to induce robust neutralizing antibodies and multifunctional T-cell immunity in seropositive aged murin	28
Risk and safety profile in checkpoint inhibitors on non-small-cell lung cancer: A systematic review	28
Safety and immunogenicity of inactive vaccines as booster doses for COVID-19 in Türkiye: A randomized trial	28
The role of age, sex, and ethnicity in vaccine trust, and sources of information in Canada: Findings from a national survey	27
An analysis of reported cases shoulder injury related to vaccine administration of after COVID-19 vaccination	27
A review of technological developments in lipid nanoparticle application for mRNA vaccination	27
Disparities in full immunization coverage among urban and rural children aged 12-23 months in southwest Ethiopia: A comparative cross-sectional study	27
Public health impact of herpes zoster vaccination on older adults in Hong Kong	27
Exploring mother-daughter communication and social media influence on HPV vaccine refusal for daughters aged 9-17 years in a cross-sectional survey of 11,728 mothers in China	26
Omalizumab added to allergen immunotherapy increased the effect of therapy in patients with severe local allergic rhinitis	26
Covid-19 vaccines elicit effective IgG responses in an elderly thymus cancer patient with chemotherapy	26
Antibody response to sequential vaccination with cell culture, recombinant, or egg-based influenza vaccines among U.S. adults	26
Cost-effectiveness of the adjuvanted RSVPreF3 vaccine among adults aged ≥60 years in the United States	26
COVID-19 vaccine acceptance in three rural communes in Haiti: A cross-sectional study	26
Autologous engineered T cell receptor therapy in advanced cancer	25
Vaccine literacy among Italian travelers: A web-based survey using a brief assessment tool	25
Pandemic paradox: How the COVID-19 crisis transformed vaccine hesitancy into a two-edged sword	25
Bibliometric and visual analysis of vaccination hesitancy research from 2013 to 2022	25
Validation of self-reported human papillomavirus vaccination in young adult men who have sex with men	24
Equivalence of freeze-dried and liquid-frozen formulations of MVA-BN as smallpox and mpox vaccine	24
Cross-reactive humoral immunity of clade 2 Oka and MAV/06 strain-based varicella vaccines against different clades of varicella–zoster virus	24
Understanding the impact process of vaccine adoption for COVID-19	24
Multilevel perspectives on school-based opportunities to improve HPV vaccination among medically underserved adolescents: Beyond school entry mandates	24
Adverse events following immunization surveillance on two types of enterovirus 71 vaccines: A real-world comparative study in China	23
“They were saying that it’s the end of the world”: Experiences of COVID-19 and beliefs about the COVID-19 vaccine among refugees in Rhode Island, US	23
Analysis on the characteristics of delayed EV71 vaccination among children in the birth cohort from 2017 to 2022	23
Human vaccines and immunotherapeutics: News July 2025	23
A video-based educational intervention to improve vaccine acceptance for Schistosomiasis japonicum: A pre–post study using the 5C model in rural China	23
COVID-19 vaccine hesitancy between teachers and students in a college, a cross-sectional study in China	23
Herpes zoster vaccination and vaccine preferences among persons aged 50–64 years in Australia: Findings from a discrete choice experiment	23
The long-term impact of vaccine clinical research on national stakeholders involved: Experience from a low-income Country	23
Access to a protected setting vaccination for allergic patients: Evaluation of appropriateness. The experience of Bari Policlinico University Hospital	23
A new quadrivalent meningococcal tetanus toxoid conjugate vaccine: Menquadfi® (MENACWY-TT)	23
Vaccine confidence and information sources among children and adolescents: A national cross-sectional survey	22
Association between combination COVID-19-influenza vaccination and long COVID in middle-aged and older Europeans: A cross-sectional study	22
Safety of COVID-19 Pfizer-BioNtech (BNT162b2) mRNA vaccination in adolescents aged 12–17 years: A systematic review and meta-analysis	22
Analysis on the epidemiological characteristics of varicella and breakthrough case from 2014 to 2022 in Qingyang City	22
State of pneumococcal vaccine immunity	22
Disparate kinetics in immune response of two different Haemophilus influenzae type b conjugate vaccines: Immunogenicity and safety observations from a randomized control	22
Using big data to analyze the vaccination status of children with congenital heart disease in Yinzhou District, China	22
Cost-effectiveness analysis of sugemalimab plus chemotherapy for the first-line treatment of advanced gastric cancer or gastroesophageal junction cancer	22
Impact of immunization strategies, public health and social measures on the incidence of varicella among children aged 0–14 years in Quzhou City	22
Enhancing vaccine effectiveness in the elderly to counter antibiotic resistance: The potential of adjuvants via pattern recognition receptors	22
Trends in hospitalization and death rates among patients with head and neck cancer in Spain, 2009 to 2019	22
Influenza vaccination landscape in Italy: A comprehensive study through the OBVIOUS project lens	22
Safety and durability of influenza and SARS-CoV-2 antibody responses through 6 months after a single dose of mRNA-1083, a multicomponent influenza and COVID-19 vaccine, in adults ≥50 years	21
Misconceptions and knowledge gaps about HPV, cervical cancer, and HPV vaccination among Central American immigrant parents in the United States	21
Effectiveness, immunogenicity, and safety of the quadrivalent HPV vaccine in women and men aged 27–45 years	21
Validation of an interferon-gamma enzyme-linked immunosorbent spot assay to evaluate cell-mediated immunity against severe acute respiratory syndrome coronavirus 2	21
Effect of difference between EV-A71 virus epidemic strain and “vaccine strain” on neutralizing antibody titer	21
HV&I reviewer highlight	21
Another measles outbreak in the Philippines? The essentiality of a successful vaccination program and public cooperation	21
The efficacy of immune checkpoint inhibitors in metastatic castration-resistant prostate cancer: A meta-analysis and reconstructed individual patient data analysis	21
Safety and immunogenicity of full-dose quadrivalent influenza vaccine in children 6–35 months of age in China: A randomized, double-blind, clinical trial	21
Case report: Leptomeningeal metastasis of advanced nasopharyngeal carcinoma treated with chemoimmunotherapy	21
RSV disease in infants and young children: Can we see a brighter future?	21
Mini-review on the therapeutic vaccines targeting chronic infectious diseases: Evaluation system of therapeutic vaccines targeting HPV and EBV-related cancers	21
Tebentafusp (IMCgp100), a first in class immune-mobilizing monoclonal T-cell receptors against cancer (ImmTAC) for HLA-A*02:01 positive uveal melanoma: Product review	21
The contributions of T cell-mediated immunity to protection from vaccine-preventable diseases: A primer	21
Long-term survival after immunotherapy and targeted therapy without chemotherapy in an elderly patient with HER2-positive gastroesophageal junction cancer: A case report	21
Role of gastroenterologists and healthcare providers in promoting COVID-19 immunization among individuals with inflammatory bowel disease: A systematic review and meta-analysis on a global scale	21
Comment on “Bidirectional crosstalk between the epithelial-mesenchymal transition and immunotherapy: A bibliometric study”	20
COVID-19 vaccine acceptance rate and its predictors in Ethiopia: A systematic review and meta-analysis	20
Factors influencing attitudes toward vaccine safety and vaccine effectiveness amongst UK healthcare professionals prior to and at the time of COVID-19 vaccine rollout: Insights from the CoPE-HCP cohor	20
Response to Letter to the Editor by Amnuay Kleebayoon, Viroj Wiwanitkit titled: Hesitancy toward vaccination against COVID-19	20
2024 List of Reviewers	20
Cost-effectiveness of a behavioral insights-informed digital campaign to increase HPV vaccination in Bangladesh	19
Results of a phase I/IIa trial of SV-BR-1-GM inoculation with low-dose cyclophosphamide and interferon alpha (Bria-IMT) in metastatic breast cancer	19
Survey of pediatricians concerning the human papillomavirus vaccine in Japan: Positive attitudes toward vaccination during the period of proactive recommendation being withheld	19
Using the power of innate immunoprofiling to understand vaccine design, infection, and immunity	19
COVID-19 vaccine booster dose hesitancy among key groups: A cross-sectional study	19
Comparing factors influencing seasonal influenza vaccine acceptance and intentions among Chinese university students residing in China and UK: A cross-sectional study	19
Parental intention on getting children COVID-19 vaccinations: Invariance evaluation across parenting roles and COVID-19-like symptoms experiences among Iranians during the pandemic period	19
Vaccine hesitancy and its determinants among refugee parents resettled in Aotearoa New Zealand	19
Is vaccine hesitancy related to mental health after the adjustment of the zero-COVID-19 strategy in the elderly? A mediation analysis in China	19
The attitude and knowledge of pediatricians and family physicians toward COVID-19 vaccination in children: A cross-sectional study	19
Changes in 23-valent pneumococcal polysaccharide vaccination rate and associated factors in 2022 and 2024 among community-based older adults in Shanghai, China	19
Lessons learned from 2 years of influenza vaccinations in the UK and USA during the COVID-19 pandemic as respiratory viruses return	19

Closer adult child–parent relations the stronger the vaccine hesitancy: A cross-sectional study of adult Children’s attitudes toward pneumococcal vaccination of elderly parents and its determinants in	18
Seroepidemiological survey of the population 10 years after the implementation of the varicella vaccine 2-dose immunization strategy	18
Exploring nurses’ experiences with a school-located influenza vaccination program: A qualitative study in the region of Murcia, Spain	18
“Same principles, different decisions”: A qualitative study exploring the attitudes of COVID-19 vaccination among school staff in Switzerland	18
Efficacy, immunogenicity, and safety of heterologous boosting with a novel chimera Chinese mRNA (RQ3013) SARS-CoV-2 vaccine: A randomized, double-blind, active-controlled trial	18
Development of a novel multi-epitope mRNA vaccine candidate to combat HMPV virus	18
Spatiotemporal distribution and determinants of immunization among children aged 12–23 months in Ethiopia: Using EDHS 2000, 2005, 2011, and 2016	18
Comparative analysis of immunogenicity between first-dose measles-mumps-rubella (MMR) vaccine administration and combined MMR-rotavirus vaccination	18
11th Immunotherapy of Cancer conference (ITOC): A meeting report	18
Mpox vaccination hesitancy and its associated factors among the general population in China: A national observational study	18
Immunogenicity, safety, and tolerability of a β-glucan-CpG-adjuvanted respiratory syncytial virus vaccine in Japanese healthy participants aged 60 to 80 years: A phase 2, randomized, double-blind, dos	18
Analysis on willingness and its influencing factors of influenza vaccination among HCWs in Quzhou in 2022–2023 influenza season	18
Transmission patterns of pertussis in school-based clustered outbreaks: A retrospective analysis in Zhejiang Province, China, 2024	18
Development of mRNA rabies vaccines	18
Vaccination in the shadow of uncertainty: Exploring the links between government trust and COVID-19 vaccine acceptance	18
Human papillomavirus (HPV) vaccine clinical trials: A cross-sectional analysis of clinical trials registries	18
Immunogenicity persistence after four intramuscular triple-dose or standard-dose hepatitis B vaccine in patients receiving methadone maintenance treatment: A 1-year follow-up study in China	18
Modifying non-coding regions of linear DNA vaccines to explore the interplay of expression and inflammation in immunogenicity	18
A study on the willingness and influencing factors of non-EPI vaccines recommendations among Chinese vaccination staff under major infectious disease outbreaks	18
Seasonal influenza vaccination uptake among health and medical college students: A discrete choice experiment	18
Management of MOG antibody-associated disease by pembrolizumab and radiation myelopathy in an elderly patient: A case report and literature review	17
Review of the unmet medical need for vaccination in adults with immunocompromising conditions: An Indian perspective	17
A community-wide epidemic of hepatitis A virus genotype IA associated with consumption of shellfish in Yantai, eastern China, January to March 2020	17
Advancements in the development of nucleic acid vaccines for syphilis prevention and control	17
Comment on: “Efficacy and safety of tebentafusp in patients with metastatic uveal melanoma: A systematic review and meta-analysis”	17
Immunogenicity and tolerability of a bivalent virus-like particle norovirus vaccine candidate in children from 6 months up to 4 years of age: A phase 2 randomized, double-blind trial	17
Respiratory syncytial virus immunization with nirsevimab: Acceptance and satisfaction assessment in infants and risk groups in the region of Murcia (Spain)	17
Correlates of uptake of COVID-19 vaccines and motivation to vaccinate among Malawian adults	17
A systematic review of gastritis as an immune-related adverse event in clinical interventions	17
Overcoming barriers to HPV vaccination in rural Vermont through a multicomponent peer-based approach	17
Association of provider HPV vaccination training with provider assessment of HPV vaccination status and recommendation of HPV vaccination	17
The impact of COVID-19 and catch-up strategies on routine childhood vaccine coverage trends in Latin America: A systematic literature review and database analysis	17
A retrospective audit of neonatal BCG vaccination in Grampian, Scotland	17
Safety Surveillance for Hepatitis A Vaccine using the U.S. Vaccine Adverse Event Reporting System (VAERS) database	17
Pneumonia hospitalizations of children aged <2 years in Poland before (2013–2016) and after (2017–2018) universal mass vaccination with 10-valent pneumococcal non-typeable Haemophilu	17
Cost-effectiveness and epidemiological impact of gender-neutral HPV vaccination in Spain	16
Safety and immunogenicity of a modified mRNA-lipid nanoparticle vaccine candidate against COVID-19: Results from a phase 1, dose-escalation study	16
Human vaccines & immunotherapeutics: News December 2022	16
Human vaccines & immunotherapeutics: News March 2023	16
Diverse processes in rotavirus vaccine development	16
The approach of World Health Organization to articulate the role and assure impact of vaccines against antimicrobial resistance	16
Immunogenicity and safety of the non-typable Haemophilus influenzae – Moraxella catarrhalis (NTHi-Mcat) vaccine administered following the	16
Prospective, multi-center post-marketing surveillance cohort study to monitor the safety of the human papillomavirus-16/18 AS04-adjuvanted vaccine in Chinese girls and women aged 9 to 45 years, 2018–2	16
Correction	16
Immunity gap for measles in young adults: Seroprevalence study in blood donors in southern Italy	16
Enhancing routine immunization efforts for older adults and frail individuals: Good practices during the SARS-CoV-2 pandemic in Italy	16
Response to comment on: “Efficacy and safety of tebentafusp in patients with metastatic uveal melanoma: A systematic review and meta-analysis”	16
Navigating vaccine hesitancy: Strategies and dynamics in healthcare professional-parent communication	16
Malawi vaccination drive: An integrated immunization campaign against typhoid, measles, rubella, and polio; health benefits and potential challenges	16
Respiratory syncytial virus immunization in children: The old, the new and what’s just around the corner	16
Establishment of the 1st Chinese national standard for CA6 neutralizing antibody	16
Comprehensive immunoprofiling and systematic adjuvant comparisons for identifying suitable vaccine: Adjuvant pairings	16
The research status and prospects of MUC1 in immunology	16
Humoral response against spike protein enhanced by fifth and sixth COVID-19 mRNA vaccine in the uninfected and infected subjects	16
Driving consistency: CEPI-Centralized Laboratory Network’s conversion factor initiative for SARS-CoV-2 clinical assays used for efficacy assessment of COVID vaccines	16
Meningococcal serogroup B vaccination series initiation in the United States: A real-world claims data analysis	16
Analysis of public opinion polls about COVID-19 vaccines: Theoretical and policy implications for vaccine communication and campaigns to address vaccine hesitancy	16
Economic burden of respiratory syncytial virus disease in Latin America: A systematic review	16
Parents’ preference for the inclusion of pediatric vaccines in the Chinese National Immunization Program: A discrete choice experiment	15
The complicated use of dupilumab in the treatment of atypical generalized pemphigus erythematosus: A report of two cases	15
Proportion of births protected against neonatal tetanus and its associated factors among mothers who gave birth within the past 6 months in Gozamn district, Northwest Ethiopia, 2022	15
Bibliometric analysis of dendritic cell-based vaccines over the past 15 years	15
Association between depression and three key COVID-19-related outcomes: The SHARE study	15
Documented vaccination as proof of immunity compared to serology in medical students	15
Thromboembolism after Astra Zeneca COVID-19 vaccine: Not always PF4- antibody mediated	15
Protein nanocages: A new frontier in mucosal vaccine delivery and immune activation	15
The safety and immunogenicity of inactivated rotavirus vaccine delivered by a dissolving microneedle patch in rats	15
Tumor vaccines: Toward multidimensional anti-tumor therapies	15
Prevalence of Neisseria meningitidis serogroups in invasive meningococcal disease in China, 2010 - 2020: a systematic review and meta-analysis	15
Outbreak report of rotavirus gastroenteritis among remotely vaccinated travelers: A potential implication of booster vaccine for travelers to endemic countries	15
Clinical and economic burden of herpes zoster in Mexico: A retrospective medical chart analysis in a private healthcare setting	15
Efficacy and safety analysis of immune checkpoint inhibitor rechallenge in advanced esophageal squamous cell carcinoma: A retrospective study	15
Parents’ willingness to vaccinate their daughters with human papillomavirus vaccine and associated factors in Debretabor town, Northwest Ethiopia: A community-based cross-sectional study	15
Bibliometric analysis on the progress of immunotherapy in renal cell carcinoma from 2003-2022	15
Rubella immunization policy in Japan: Immunity gaps arising from program differences and inconsistent cutoff standards	15
Parental intention to vaccinate children against seasonal influenza in the Eastern Mediterranean region: A cross-sectional study using the health belief model	15
Safety and reactogenicity of the BNT162b2 COVID-19 vaccine: Development, post-marketing surveillance, and real-world data	15
Simulating rabies post-exposure prophylaxis among patients with human immunodeficiency virus infection using a six-dose Essen regimen administrated with human diploid cell vaccine: A single-arm pilot	15
Natural carrier systems in cancer vaccines and immunotherapy	15
Efficacy of vaccination against the SARS-CoV-2 virus in patients with chronic kidney disease on hemodialysis	15
Impact of COVID-19 vaccination status on hospitalization and disease severity: A descriptive study in Nagasaki Prefecture, Japan	15
Anti-inflammatory effects of immunotherapy in clinical treatment and its potential mechanism in alleviating sleeping disorders: A systematic bibliometric study	15
Risk of RSV-related hospitalization is associated with gestational age in preterm (born at 29–34 wGA) infants without outpatient palivizumab administration	14
Impact of a focus education in Zoom on COVID-19 vaccine hesitancy in Hong Kong parents of the preschoolers	14
COVID-19 vaccine acceptance and its association with knowledge and attitude among patients with chronic diseases in Ethiopia	14
Changes in dendritic complexity and spine morphology following BCG immunization in APP/PS1 mice	14
Comment on ‘exploring prognostic factors for survival in patients with advanced pancreatic cancer undergoing PD-1 inhibitor immunotherapy’	14
Response to comment on ‘Clinical characteristics and risk factors for ZF2001 fully vaccinated inpatients with COVID-19: A retrospective cohort study’	14
Commentary: Knowledge mapping of immunotherapy for breast cancer: A bibliometric analysis from 2013–2022	14
Effectiveness of cocoon strategy vaccination on prevention of influenza-like illness in young infants	14
Confidence in COVID-19 vaccine effectiveness and safety and its effect on vaccine uptake in Tanzania: A community-based cross-sectional study	14
Retrospective analysis of health and economic burden among commercially-insured individuals diagnosed with invasive meningococcal disease in the United States	14
Immune persistence and booster response of a quadrivalent meningococcal conjugate vaccine (MenACYW-TT) 5 years after primary vaccination of adults at ≥56 years of age	14
Antibody levels and immune memory in children with kaposiform hemangioendothelioma treated with sirolimus after catch up vaccination	14
Safety of the 15-valent pneumococcal conjugate vaccine: A phase I clinical trial	14